PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.

PRINCIPAL DISPLAY PANEL SHIPPER LABEL. Eisai Manufacturing Limited Allegato DQA-035/XXXXNew Chemical Entity Demand Chain Unit European Knowledge CentreMosquito Way-Hatfield, Herts, AL 109SNUnited Kingdom HALAVEN(R) (eribulin mesylate) Injection, for intravenous use- 0.5mg/ml, ml Store at 15 25C (59 77F). DO NOT FREEZE QTY: 00XXX EXP: MM-YYYY LOT: F1XXYZZZ (22) 900XXX MMYYYY F1XXYZZZ NDC 43624-002-01(0X) 50X XXXXX 00X X0 XXX Manufactured by BSP Pharmaceuticals SpA-Latina Scalo, Italy. Image (eribulin mesylate) Injection1 mg/2 mL(0.5 mg/mL)For Intravenous Use.

SPL UNCLASSIFIED SECTION.

Halaven(R). (eribulin mesylate) Injection, for intravenous use mg/2 mL (0.5 mg/mL).